Skip to main content

Table 2 A summarizing list of inhibitors designed and developed in order to inhibit the binding of PDZ-containing proteins involved in different human pathologies (light red, yellow, and light violet respectively for cancer, cystic fibrosis, and nervous system disorders)

From: Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer

  1. *Inhibitor in phase III trial